1. Home
  2. RCKT vs ROCK Comparison

RCKT vs ROCK Comparison

Compare RCKT & ROCK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCKT
  • ROCK
  • Stock Information
  • Founded
  • RCKT 1999
  • ROCK 1972
  • Country
  • RCKT United States
  • ROCK United States
  • Employees
  • RCKT 299
  • ROCK N/A
  • Industry
  • RCKT Biotechnology: Pharmaceutical Preparations
  • ROCK
  • Sector
  • RCKT Health Care
  • ROCK
  • Exchange
  • RCKT Nasdaq
  • ROCK Nasdaq
  • Market Cap
  • RCKT 264.0M
  • ROCK 1.5B
  • IPO Year
  • RCKT N/A
  • ROCK 1993
  • Fundamental
  • Price
  • RCKT $2.81
  • ROCK $60.54
  • Analyst Decision
  • RCKT Buy
  • ROCK
  • Analyst Count
  • RCKT 13
  • ROCK 0
  • Target Price
  • RCKT $18.50
  • ROCK N/A
  • AVG Volume (30 Days)
  • RCKT 4.2M
  • ROCK 237.3K
  • Earning Date
  • RCKT 08-04-2025
  • ROCK 07-30-2025
  • Dividend Yield
  • RCKT N/A
  • ROCK N/A
  • EPS Growth
  • RCKT N/A
  • ROCK 16.71
  • EPS
  • RCKT N/A
  • ROCK 4.34
  • Revenue
  • RCKT N/A
  • ROCK $1,306,273,000.00
  • Revenue This Year
  • RCKT N/A
  • ROCK $11.02
  • Revenue Next Year
  • RCKT N/A
  • ROCK $8.19
  • P/E Ratio
  • RCKT N/A
  • ROCK $13.94
  • Revenue Growth
  • RCKT N/A
  • ROCK N/A
  • 52 Week Low
  • RCKT $2.19
  • ROCK $48.96
  • 52 Week High
  • RCKT $26.98
  • ROCK $81.90
  • Technical
  • Relative Strength Index (RSI)
  • RCKT 40.19
  • ROCK 53.07
  • Support Level
  • RCKT $2.40
  • ROCK $58.41
  • Resistance Level
  • RCKT $2.96
  • ROCK $62.51
  • Average True Range (ATR)
  • RCKT 0.21
  • ROCK 1.88
  • MACD
  • RCKT 0.15
  • ROCK 0.22
  • Stochastic Oscillator
  • RCKT 61.65
  • ROCK 62.54

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.

About ROCK Gibraltar Industries Inc.

Gibraltar Industries Inc manufactures and provides products and services for the Renewable energy, Residential, Agtech, and Infrastructure markets. The Renewables Segment is engaged in designing, engineering, manufacturing, and installing solar racking and electrical balance systems. Agtech Segment provides growing and processing solutions including the designing, engineering, manufacturing, full-scope construction, maintenance, and support of greenhouses and indoor growing operations, and botanical extraction systems. It derives key revenue from the Residential segment which offers roof and foundation ventilation products, single point and centralized mail systems electronic package solutions, and Retractable awnings and gutter guards, among other products.

Share on Social Networks: